Lecanemab, a new drug for treating Alzheimer´s disease, has been hailed as a major breakthrough. But is that truly the case? In this quick commentary, I will guide you through some details of the study.
Note: This video was finished amidst my move from NYC to Helsinki, so please bear with the very basic edit.
References: